Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
01/2009
01/08/2009WO2008074450A3 Non-peptidic renin inhibitors nitroderivatives
01/08/2009US20090012297 Ionic liquids as solvents
01/08/2009US20090012093 Receptor Function Regulator
01/08/2009US20090011994 Non-basic melanin concentrating hormone receptor-1 antagonists and methods
01/08/2009DE102007031220A1 Chinoide Verbindungen und deren Verwendung in halbleitenden Matrixmaterialien, elektronischen und optoelektronischen Bauelementen Quinoid compounds and their use in semi-conductive matrix materials, electronic and optoelectronic devices
01/08/2009CA2694264A1 Substituted piperazines as cb1 antagonists
01/08/2009CA2694253A1 Substituted piperazines as cb1 antagonists
01/08/2009CA2692268A1 Substituted piperazines as cb1 antagonists
01/07/2009EP2010183A2 Processes for synthesizing 7-alkynyl-4-aminoquinazolines and a related intermediate
01/07/2009CN101341137A Pyrazine derivatives as epithelial sodium channel blocker
01/07/2009CN101341136A Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same
01/07/2009CN101341135A Novel substituted pyrazinone derivatives for use in MCH-1 mediated diseases
01/07/2009CN100448849C Process for preparing 4-acyl substituted-2-methylpiperazines
01/06/2009US7473692 Sulfonamide derivatives as D3-receptor ligands
01/06/2009US7473690 Tetralin and indane derivatives and uses thereof
01/06/2009CA2227851C Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives
01/01/2009US20090005562 N-(2,4,6-triisopropylphenylsulfonyl)-3-amidino(or guanidino)phenyl-alanine 4-ethoxycarbonylpiperazide; urokinase inhibitors; reacting a 3-cyanophenylalanine with a quaternary ammonium hydroxide and reacting the product with a phenylsulfonyl halide; industrial scale; simplification; cost efficiency
01/01/2009US20090005561 Heterocyclical Chromophore Architectures
01/01/2009US20090005390 Novel quinuclidine derivatives and their use
01/01/2009US20090005380 Cyclohexyl derivatives
01/01/2009US20090005370 Isoxazole-imidazole derivatives
01/01/2009US20090005323 Cathepsin K Inhibitors and Obesity
12/2008
12/31/2008WO2009001817A1 COMPOUND HAVING 11β-HSD1 INHIBITORY ACTIVITY
12/31/2008WO2009001132A1 Pyrazinone derivatives and their use in the treatment of lung diseases
12/31/2008EP2009004A1 Novel piperazine compound, and use thereof as hcv polymerase inhibitor
12/31/2008EP2008210A1 Modulation of phosphoryl transferase activity of glutamine synthetase
12/31/2008EP2007717A1 Novel sulfonamide compounds
12/31/2008EP1051397B1 Method for preparing an n- (aliphatic or aromatic)carbonyl -2-aminoacetamide compound and a cyclyzed compound
12/31/2008CN101333195A Method for harnessing and recovering producing waste water of cyadox
12/31/2008CN101333194A Method for preparing quizalofop-p-ethyl
12/31/2008CA2691215A1 Pyrazinone derivatives and their use in the treatment of lung diseases
12/30/2008US7470817 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried
12/30/2008US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
12/30/2008US7470722 For treating disease, such as cancer, neurological disorders, including polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, autoimmune diseases and cardiovascular conditions
12/30/2008CA2351703C Novel 4-dedimethylaminotetracycline derivatives
12/25/2008US20080318975 Prevent transplant rejection
12/25/2008US20080318969 Anti-anginal compounds
12/25/2008US20080318962 Fungicides Based on Nitrogen-Containing Heterocycles
12/25/2008US20080318958 New utilities of tricyclic compounds
12/25/2008US20080318956 Inflammatory cytokine release inhibitor
12/25/2008US20080318945 Novel Compounds
12/25/2008US20080318923 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle
12/25/2008US20080317806 Antiparasitic Compounds
12/24/2008WO2008157240A1 Substituted piperazines
12/24/2008WO2008076685A3 Process for the preparation of piperazinyl and diazepanyl benzamide derivatives
12/24/2008WO2008013840A3 Erastin analogs and uses thereof
12/24/2008EP2004616A1 Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative
12/24/2008EP2004595A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
12/24/2008EP1599096B1 Hetero substitued sodium channel blockers
12/24/2008CN100445276C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
12/24/2008CN100445266C MCH antagonists and their use in treatment of obesity
12/24/2008CN100444839C Treatment of chemokine mediated diseases
12/24/2008CA2690379A1 Substituted piperazines
12/23/2008US7468393 Diarylsulfones as 5-HT2A antagonists
12/23/2008US7468368 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
12/23/2008US7468367 depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis/disorder; depressive neurosis/disorder, anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; sex disorder, sexual disorder; schizophrenia; manic depression;
12/23/2008CA2331685C Use of compounds for the elevation of pyruvate dehydrogenase activity
12/18/2008WO2008152306A2 Novel peptidase substrates
12/18/2008WO2008152305A2 Novel nitroreductase enzymatic substrates
12/18/2008WO2008152073A2 Piperazine compounds with a herbicidal action
12/18/2008WO2008152072A2 Piperazine compounds with a herbicidal action
12/18/2008WO2008079339A3 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
12/18/2008US20080312247 Substituted piperazines
12/18/2008US20080312244 Squaric Acid Derivatives as Protein Kinase Inhibitors
12/18/2008US20080312231 N-{2-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-2-oxo-ethoxy]-ethyl}-N-ethyl-4-methoxy-2,3,6-trimethyl-phenylsulfonamide; condensing the N-carboxyalkyl phenylsulfonamide with the substituted piperidine; bradykinin receptor antagonists; analgesics; antidiabetics; angiogenesis inhibitors; rheumatic diseases
12/18/2008US20080312216 Piperazine and [1,4]diazepan derivatives as nk antagonists
12/18/2008US20080312212 Organic Compounds
12/18/2008US20080312207 Compounds
12/18/2008CA2689529A1 Piperazine compounds having herbicidal action
12/18/2008CA2689209A1 Piperazine compounds having herbicidal action
12/17/2008EP2001857A2 Photoactive compounds and compositions and uses thereof
12/17/2008EP2001476A2 Benzoimidazolyl-parazine compounds for inflammation and immune-related uses
12/17/2008EP1773763B1 Lysine based compounds
12/17/2008EP1322654B1 Platinum complexes as antitumour agents
12/17/2008EP1282609B1 Piperazinedione compounds
12/17/2008CN101323599A Chemical synthesis method for 2-formylcyanoacetylhydrazone-quinoxaline-1,4-dioxide
12/17/2008CN100443475C Compound of 2-substituted alkylacrylate and application thereof
12/16/2008US7465726 Substituted pyrrolo[2.3-B]pyridines
12/11/2008WO2008148867A2 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases
12/11/2008US20080306259 Hydroxylation of beta-dicarbonyls with zirconium catalysts
12/11/2008US20080306258 Cyclopropane compounds and pharmaceutical use thereof
12/11/2008US20080306239 Quinoxaline-containing compounds and polymers thereof
12/11/2008US20080306090 Thiourea derivatives
12/11/2008US20080306066 Non-imidazole heterocyclic compounds
12/11/2008US20080306054 Pharmaceutical Compounds
12/11/2008US20080305082 1,4-Bis-N-Oxide-5,8- Dihydroxyanthracenedione Compounds and the Use Thereof
12/11/2008US20080303423 Novel Materials For Organic Electroluminescent Devices
12/11/2008CA2690288A1 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases
12/10/2008EP1999117A2 Renin inhibitors
12/10/2008EP1998761A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
12/10/2008CN101321773A Organometallic complex and light-emitting element, light-emitting device and electronic device using the same
12/10/2008CN101318940A Quinoxaline-containing compounds and polymers thereof
12/10/2008CN101318939A Method for preparing medicament midbody 5-bromine-6-amido quinoxaline
12/10/2008CN101318938A Method for synthesizing quinoxaline derivant
12/10/2008CN101318937A Alkaloid compounds, preparation method and application thereof
12/09/2008US7462629 Therapy or prevention diseases caused by lymphocyte interaction; antiinflammatory agents; autoimmune disease
12/09/2008US7462619 Pyridazine, pyrimidine and pyrazine ethyne compounds
12/09/2008US7462617 Substituted acylpiperazine derivatives
12/09/2008CA2379061C Antibacterial agents
12/04/2008WO2008146914A1 Heterocyclic compound
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 187